Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication

<p style="text-align:justify;"> <b>Background:</b> Although some interventions have been shown to improve adherence to medication for diabetes, results are not consistent. We have developed a theory-based intervention which we will evaluate in a well characterised popula...

ver descrição completa

Detalhes bibliográficos
Principais autores: Farmer, A, Prevost, A, Hardeman, W, Craven, A, Sutton, S, Griffin, S, Kinmonth, A
Formato: Journal article
Idioma:English
Publicado em: BioMed Central 2008
_version_ 1826303934839390208
author Farmer, A
Prevost, A
Hardeman, W
Craven, A
Sutton, S
Griffin, S
Kinmonth, A
author_facet Farmer, A
Prevost, A
Hardeman, W
Craven, A
Sutton, S
Griffin, S
Kinmonth, A
author_sort Farmer, A
collection OXFORD
description <p style="text-align:justify;"> <b>Background:</b> Although some interventions have been shown to improve adherence to medication for diabetes, results are not consistent. We have developed a theory-based intervention which we will evaluate in a well characterised population to test efficacy and guide future intervention development and trial design.<br/><br/> <b>Methods and Design:</b> The SAMS (Supported Adherence to Medication Study) trial is a primary care based multi-centre randomised controlled trial among 200 patients with type 2 diabetes and an HbA1c of 7.5% or above. It is designed to evaluate the efficacy of a two-component motivational intervention based on the Theory of Planned Behaviour and volitional action planning to support medication adherence compared with standard care. The intervention is delivered by practice nurses. Nurses were trained using a workshop approach with role play and supervised using assessment of tape-recorded consultations. The trial has a two parallel groups design with an unbalanced three-to-two individual randomisation eight weeks after recruitment with twelve week follow-up. The primary outcome is medication adherence measured using an electronic medication monitor over 12 weeks and expressed as the difference between intervention and control in mean percentage of days on which the correct number of medication doses is taken. Subgroup analyses will explore impact of number of medications taken, age, HbA1c, and self-reported adherence at baseline on outcomes. The study also measures the effect of dispensing medication to trial participants packaged in the electronic medication-monitoring device compared with conventional medication packaging. This will be achieved through one-to-one randomisation at recruitment to these conditions with assessment of the difference between groups in self-report of medication adherence and change in mean HbA1c from baseline to eight weeks. Anonymised demographic data are collected on non-respondents. Central randomisation is carried out independently of trial co-ordination and practices using minimisation to adjust for selected confounders.<br/><br/> <b>Discussion:</b> The SAMS intervention and trial design address weaknesses of previous research by recruitment from a well-characterised population, definition of a feasible theory based intervention to support medication taking and careful measurement to estimate and interpret efficacy. The results will inform practice and the design of a cost-effectiveness trial [ISRCTN30522359]. </p>
first_indexed 2024-03-07T06:10:13Z
format Journal article
id oxford-uuid:ef39d95e-3b11-4fbd-8486-fde4b006dc41
institution University of Oxford
language English
last_indexed 2024-03-07T06:10:13Z
publishDate 2008
publisher BioMed Central
record_format dspace
spelling oxford-uuid:ef39d95e-3b11-4fbd-8486-fde4b006dc412022-03-27T11:38:48ZProtocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medicationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ef39d95e-3b11-4fbd-8486-fde4b006dc41EnglishSymplectic Elements at OxfordBioMed Central2008Farmer, APrevost, AHardeman, WCraven, ASutton, SGriffin, SKinmonth, A <p style="text-align:justify;"> <b>Background:</b> Although some interventions have been shown to improve adherence to medication for diabetes, results are not consistent. We have developed a theory-based intervention which we will evaluate in a well characterised population to test efficacy and guide future intervention development and trial design.<br/><br/> <b>Methods and Design:</b> The SAMS (Supported Adherence to Medication Study) trial is a primary care based multi-centre randomised controlled trial among 200 patients with type 2 diabetes and an HbA1c of 7.5% or above. It is designed to evaluate the efficacy of a two-component motivational intervention based on the Theory of Planned Behaviour and volitional action planning to support medication adherence compared with standard care. The intervention is delivered by practice nurses. Nurses were trained using a workshop approach with role play and supervised using assessment of tape-recorded consultations. The trial has a two parallel groups design with an unbalanced three-to-two individual randomisation eight weeks after recruitment with twelve week follow-up. The primary outcome is medication adherence measured using an electronic medication monitor over 12 weeks and expressed as the difference between intervention and control in mean percentage of days on which the correct number of medication doses is taken. Subgroup analyses will explore impact of number of medications taken, age, HbA1c, and self-reported adherence at baseline on outcomes. The study also measures the effect of dispensing medication to trial participants packaged in the electronic medication-monitoring device compared with conventional medication packaging. This will be achieved through one-to-one randomisation at recruitment to these conditions with assessment of the difference between groups in self-report of medication adherence and change in mean HbA1c from baseline to eight weeks. Anonymised demographic data are collected on non-respondents. Central randomisation is carried out independently of trial co-ordination and practices using minimisation to adjust for selected confounders.<br/><br/> <b>Discussion:</b> The SAMS intervention and trial design address weaknesses of previous research by recruitment from a well-characterised population, definition of a feasible theory based intervention to support medication taking and careful measurement to estimate and interpret efficacy. The results will inform practice and the design of a cost-effectiveness trial [ISRCTN30522359]. </p>
spellingShingle Farmer, A
Prevost, A
Hardeman, W
Craven, A
Sutton, S
Griffin, S
Kinmonth, A
Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
title Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
title_full Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
title_fullStr Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
title_full_unstemmed Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
title_short Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
title_sort protocol for sams support and advice for medication study a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
work_keys_str_mv AT farmera protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication
AT prevosta protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication
AT hardemanw protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication
AT cravena protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication
AT suttons protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication
AT griffins protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication
AT kinmontha protocolforsamssupportandadviceformedicationstudyarandomisedcontrolledtrialofaninterventiontosupportpatientswithtype2diabeteswithadherencetomedication